Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Community Health Systems, Inc.

CYHNYSE
Wall Street Score · overall investment25/100
$2.65USD$-0.18 (-6.51%)
Company website www.chs.net
Headquarters4000 Meridian Boulevard, Franklin, TN, 37067, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Care Facilities
Price updated todayFinancials updated Oct 1, 2026

CYH · Price history

Price at last available close

$2.66

−$0.23 (-7.96%) 1M

2026-10-28

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Community Health Systems, Inc.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical services, including emergency care, general and specialized surgical procedures, critical care, internal medicine, obstetrics, and various diagnostic capabilities. Additionally, they provide psychiatric services, rehabilitation programs, skilled nursing, and in-home care.

How they make money

Community Health Systems, Inc. generates revenue primarily by providing healthcare services through its network of affiliated hospitals and outpatient facilities. The company receives payments for these services from various sources, including government programs like Medicare and Medicaid, as well as private managed care organizations and other third-party payors.

Products & services

The company provides a range of healthcare services including general acute care, emergency services, surgical procedures, diagnostic imaging, and outpatient care through its network of hospitals and affiliated facilities.

Brands & revenue mix

No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

Customer concentration

The company is significantly dependent on government reimbursement programs, specifically Medicare and Medicaid, which represent a substantial portion of its net operating revenues.

Suppliers, materials & equipment

  • Medical supply and pharmaceutical distributors — The company relies on various third-party vendors for medical supplies, pharmaceuticals, and equipment; specific supplier names are not disclosed.Source

Strengths

  • Significant scale and standardized operating systemsSource
  • Diverse market presence across multiple statesSource

Risks

  • Dependence on government reimbursement programsSource
  • Changes in healthcare regulations and payment modelsSource

Financial risk observations and what to check

These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.

Quarterly EPS fell 75.6% versus the same quarter last year.

Review net income and weighted-average shares together. Per-share earnings can change because of operating performance, nonrecurring items or the share denominator.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

25

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

41

Weak

Financial Strength

40

Business Quality / Moat

43

Management

25

Growth Quality

76

Risk / Durability

20

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

20

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

28/100

Building Historical Record

Model Score 28/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Recent buyback activity is present
What to watch
  • •Elevated debt risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak

Company-specific research

Questions worth answering for CYH

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can CYH maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is CYH's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is CYH's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What specifically needs to improve for CYH to reach sustainable profitability?
  • •What future growth or profitability would be needed to justify CYH's current valuation?
Elevated debt risk
Business analysis: 16 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

25

0–100 · Poor

Opportunity Score

20

0–100 · Poor

Market Cap

$374.4M

P/E Ratio

-1.3

EPS

$-2.26

52-Week High

$4.43

52-Week Low

$2.40

Beta

1.86

Analyst Target

$3.00

Shares Outstanding

135.0M

Total Revenue

$22.41B

Total Debt

$10.21B

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$-8.62

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
31/ 100
-9 pts / 5d

Weakening momentum

5D -5.7% · 20D -7.0% · RSI 47 · Price vs 20D avg -6.1%
Volatility
46/ 100
+6 pts / 5d

Normal movement

20D realized vol 46.8% · 60D 35.6% · Acceleration 1.31x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for CYH

Detected from reported data — verify before acting.

Dividend history reported

Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Elevated debt risk

Negative shareholder equity • Interest coverage is below 2x • Cash covers less than 20% of total debt

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on CYH.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Significant scale and standardized operating systems.
  • +Diverse market presence across multiple states.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Debt risk (elevated): Negative shareholder equity.
  • −Interest coverage is below 2x.
  • −Cash covers less than 20% of total debt.
  • −Dependence on government reimbursement programs.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak25/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

25

Tap for breakdown →

Fair

50

Debt Cost7.5%
Debt Reduction YoY4.3%
Debt / Equity-8.31x

Tap for breakdown →

Weak

40

Revenue YoY79.5%
Revenue CAGR-0.0%
Net Margin-1.3%

Tap for breakdown →

Fair

55

Asset Growth YoY-6.0%
Liquidation/Share-$8.62
Net Assets/MCap4.89x

Tap for breakdown →

Poor

6

Earnings Yield-74.4%
Buyback Yield0.9%
Debt Cost7.5%

Tap for breakdown →

Poor

25

ROIC-106.8%
ROE21.6%
ROA-2.5%

Tap for breakdown →

Weak

43

EPS Growth42.3%
FCF/Share Growth16.6%
Rev/Share Growth-3.1%

Tap for breakdown →

Poor

0

Intrinsic Value—
Value Reference—
MOS—

Tap for breakdown →

Poor

39

Revenue40
Moat43
Valuation0

Tap for breakdown →

Poor

0

MOS %—
Value Reference—
Deep Discount Reference—

Tap for breakdown →

Poor

21

Interest Coverage-11.4x
ROIC-106.8%
FCF Yield51.6%

Tap for breakdown →

Poor

18

Financial21
Valuation0
Debt50

Tap for breakdown →

Poor

31

Survival Years0.0 yrs
Current Ratio1.46x
FCF Margin1.7%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

6 historical score records available

Previous Score

25

Sep 17, 2026

Change

Unchanged

Current Score

25

Oct 1, 2026

Category Changes

Revenue0
Debt0
Assets0
Capital0
Management0
Moat0
Valuation0
Buffett0

CYH score was unchanged.

Projected Score

Projected Score

17

Projected Change

-7.8 points

Preliminary comparable-period financial changes suggest decline of approximately 7.8 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Valuation unavailable

Current Price

$2.65

Model Intrinsic Value

—

Difference

—

Margin of Safety

—

Value Reference: —
Deep Discount Reference: —

Intrinsic value is not currently available for this stock, so valuation can't be calculated.

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$5.0B$10.0B$15.0B$20.0B

Additional Metrics

Operating Cash Flow

201520172019202120232025-$800M$0$800M$1.6B$2.4B

Total Debt

201520172019202120232025$0$4.5B$9.0B$13.5B$18.0B

Total Assets

201520172019202120232025$0$7.0B$14.0B$21.0B$28.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$22.41B$12.48B$12.63B$12.49B····························
Cost of Revenue$9.40B$11.40B$7.36B$7.41B····························
Gross Profit$13.02B$1.08B$5.27B$5.08B····························
Research & Development$0.00$0.00$0.00$80.0M····························
SG&A Expenses$11.79B$0.00$299.0M$319.0M····························
Operating Expenses$21.70B$11.00B$4.73B$4.13B····························
EBITDA$4.91B$2.02B$1.25B$1.29B····························
Operating Income-$8.68B-$9.91B$542.0M$957.0M····························
Interest Expense$856.0M$870.0M$863.0M$832.0M····························
Income Before Tax-$481.0M$724.0M-$283.0M$207.0M····························
Income Tax Expense$66.0M$48.0M$79.0M$191.0M····························
Net Income-$300.0M$509.0M-$516.0M-$133.0M····························
Basic EPS$-2.26$3.80$-3.90$-1.02····························
Basic Shares135M134M132M130M····························
Diluted Shares136M135M132M130M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:A future estimated earnings date is not currently available.
Jun 30, 2026Q2FY2026

Revenue

$4.06B

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.51

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

-11.2%

Cash Change

-67.3%

Margin Change

-7.3 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Debt reduced

What Weakened

  • Margins contracted
  • Cash position declined

Potential Score Impact

Positive indicators included revenue growth, debt levels. Pressure indicators included EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 29.7%. EPS declined 75.6%. Cash declined 67.3%. Total debt declined 11.2%. Net income margin declined by 7.3 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Earnings data: 120 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

Smart Money

Number of Gurus

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Loading data...

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Log in to view dividend history.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

6 historical records
Jul 23, 26Aug 12, 26Sep 3, 26Sep 6, 26Sep 17, 26Oct 1, 260255075100

Historical Score Chart

3 of 6 records shown
3 historical score records are shown. Start your seven-day free trial to unlock 3 more records and the complete score history.Start Free Trial

Wall Street Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Debt Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Revenue Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Asset Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Capital Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Management Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Moat Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Valuation Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Buffett Score

Sep 6, 26Sep 17, 26Oct 1, 260255075100

Intrinsic Value

No data

Value Reference

No data

Margin of Safety %

No data

Related Companies

Medical - Care Facilities

UHS

Universal Health Services, Inc.

72Strong
$186.89View

SRTA

Strata Critical Medical, Inc.

63Fair
$4.81View

NUTX

Nutex Health, Inc.

62Fair
$209.30View

ADUS

Addus HomeCare Corporation

59Fair
$118.03View

THC

Tenet Healthcare Corporation

57Fair
$269.07View

AVAH

Aveanna Healthcare Holdings Inc.

56Fair
$12.75View

News

Rumor Mill · CYH

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksStocks under $10Best healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial